I INVIVYD INC
| Market Cap | $361.72M |
| P/E Ratio | — |
| Forward P/E | -32.00 |
| Dividend Yield | — |
| Beta | 0.74 |
| 52W Range | $0.47 - $2.88 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Biotechnology |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Lee Ainslie Maverick Capital | 0.50% | $46.86M | 18,970,913 | — |
Insider Trading
| Insider Name of the company insider who made the trade 12 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Green JulieChief Human Resources Officer | Sale | 20,964 | $1.58 | $33.08K | 18 Feb 2026 | 18 Feb 2026 |
| Duke William E.Chief Financial Officer | Sale | 20,964 | $1.58 | $33.08K | 18 Feb 2026 | 18 Feb 2026 |
| Lee Timothy EdwardChief Commercial Officer | Sale | 20,964 | $1.58 | $33.08K | 18 Feb 2026 | 18 Feb 2026 |
| Andersen JillChief Legal Officer, Secretary | Sale | 34,939 | $1.58 | $55.13K | 18 Feb 2026 | 18 Feb 2026 |
| Allen Robert D. IIIChief Scientific Officer | Sale | 19,392 | $1.58 | $30.60K | 18 Feb 2026 | 18 Feb 2026 |
| Lee Timothy EdwardChief Commercial Officer | Sale | 19,663 | $1.54 | $30.27K | 17 Feb 2026 | 18 Feb 2026 |
| Andersen JillChief Legal Officer, Secretary | Sale | 32,771 | $1.54 | $50.45K | 17 Feb 2026 | 18 Feb 2026 |
| Allen Robert D. IIIChief Scientific Officer | Sale | 18,189 | $1.54 | $28.00K | 17 Feb 2026 | 18 Feb 2026 |
| Duke William E.Chief Financial Officer | Sale | 19,663 | $1.54 | $30.27K | 17 Feb 2026 | 18 Feb 2026 |
| Green JulieChief Human Resources Officer | Sale | 19,663 | $1.54 | $30.27K | 17 Feb 2026 | 18 Feb 2026 |
| MCLAUGHLIN KEVIN F | Buy | 50,000 | $2.50 | $125.00K | 19 Nov 2025 | 20 Nov 2025 |
| Kevin F MclaughlinDirector | Buy | 50,000 | $2.50 | $125.00K | 19 Nov 2025 | 20 Nov 2025 |
Frequently Asked Questions
What is IVVD stock price today?
INVIVYD INC (IVVD) is currently trading at $1.28. The stock has a 52-week range of $0.47 to $2.88 and a market capitalization of $361.72M.
Is IVVD a good stock to buy in 2026?
INVIVYD INC has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of +132.7%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling IVVD stock?
There have been 12 insider transactions for IVVD in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has IVVD stock performed over the past year?
INVIVYD INC (IVVD) has returned +132.7% over the past 12 months. The stock traded between $0.47 and $2.88 during this period, and is currently at $1.28.
Which hedge funds own IVVD (INVIVYD INC)?
1 tracked hedge funds currently hold IVVD in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is IVVD's market cap and valuation?
INVIVYD INC (IVVD) has a market capitalization of $361.72M. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is IVVD's revenue and profitability?
INVIVYD INC reported revenue of $53.43M with net income of N/A and a profit margin of N/A. The stock has a beta of 0.74.
What sector is IVVD in and who are its biggest institutional holders?
INVIVYD INC (IVVD) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.